D.E. Shaw & Co’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.98M | Sell |
|
|||||
|
2025
Q1 | $4.51M | Sell |
|
|||||
|
2024
Q4 | $8.17M | Sell |
|
|||||
|
2024
Q3 | $3.88M | Buy |
|
|||||
|
2024
Q2 | $3.65M | Buy |
|
|||||
|
2024
Q1 | $4.07M | Buy |
|
|||||
|
2023
Q4 | $2.04M | Buy |
|
|||||
|
2023
Q3 | $452K | Buy |
|
|||||
|
2023
Q2 | $300K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $332K | Sell |
|
|||||
|
2021
Q3 | $1.15M | Sell |
|
|||||
|
2021
Q2 | $4.73M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $132K | Sell |
|
|||||
|
2019
Q3 | $758K | Buy |
|
|||||
|
2019
Q2 | $1.47M | Sell |
|
|||||
|
2019
Q1 | $11.1M | Sell |
|
|||||
|
2018
Q4 | $16.8M | Buy |
|
|||||
|
2018
Q3 | $19.3M | Buy |
|
|||||
|
2018
Q2 | $25.3M | Buy |
|
|||||
|
2018
Q1 | $21.7M | Buy |
|
|||||
|
2017
Q4 | $25.2M | Buy |
|
|||||
|
2017
Q3 | $314K | Buy |
|